TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Bioxyne Limited ( (AU:BXN) ) is now available.
Bioxyne Limited has revised its Appendix 4C for the quarter ending 30 June 2025, correcting previous errors in reported cash flow figures. The updated report shows a net cash inflow from operating activities of A$1,554,000 and cash and cash equivalents at the quarter’s end totaling A$7,668,000. This correction provides a clearer picture of the company’s financial health and operational efficiency, potentially impacting stakeholder confidence and market perception positively.
More about Bioxyne Limited
Bioxyne Limited operates in the biotechnology industry, focusing on the development and commercialization of health and wellness products. The company is known for its probiotic and immune health products, catering to a market that emphasizes health and well-being.
Average Trading Volume: 4,966,452
Technical Sentiment Signal: Buy
Current Market Cap: A$115.1M
See more data about BXN stock on TipRanks’ Stock Analysis page.